Stockreport

Evommune, Inc. GAAP EPS of -$11.22, revenue of $13M [Seeking Alpha]

Evommune, Inc.  (EVMN) 
PDF Cash, cash equivalents and investments were $216.7 million as of December 31, 2025, compared to $72.0 million as of December 31, 2024. More on Evommune, Inc. Evommu [Read more]